NeuroLux is proud to announce that it has been awarded a Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH). The fund, totaling over $1.5M for two years, will support the development of next-generation devices that...
NeuroLux to attend SfN’s 47th Annual Meeting
NeuroLux will be participating in SfN’s 47th Annual Meeting, Neuroscience 2017. We will exhibit our latest wireless optogenetics system and perform cool demonstrations at booth #425! There will be 30,000 colleagues from more than 80 countries so don’t forget to register here. See you there!
NeuroLux system is available in Japan!
Through strategic partnership with Physio-tech co.ltd., NeuroLux optogenetics system is available in Japan! Physio-tech is a Tokyo-based company that specializes in medical research laboratory equipment for research groups at universities, national laboratories, pharmaceutical companies, and hospitals. Click here to go to Physio-tech website!
Rogers and NeuroLux Featured in C&EN
On February 6th, 2017, Chemical and Engineering News (C&EN) discusses the crucial role of chemistry and materials science in optogenetics advancement. The article features Professor John A. Rogers, NeuroLux co-founder, and describes his collaborative effort with the other co-founders and their respective research groups in creating NeuroLux technology. One of...